This inventor holds 1 USPTO granted patent. Top assignee: Beigene, Ltd.. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Innovations in Immunotherapy by Zhong Wu
Introduction
Zhong Wu is a notable inventor based in Fort Lee, NJ (US). He has made significant contributions to the field of immunotherapy, particularly in the treatment of hepatocellular carcinoma. His innovative approach has the potential to improve outcomes for patients suffering from this challenging condition.
Latest Patents
Zhong Wu holds a patent for a method aimed at the prevention, delay of progression, or treatment of hepatocellular carcinoma. This patent, which involves administering a therapeutically effective amount of an anti-PD-1 antibody, specifically targets human PD-1. His work in this area is crucial for advancing cancer treatment options.
Career Highlights
Zhong Wu is currently associated with BeiGene, Ltd., a company known for its focus on molecularly targeted and immuno-oncology drug discovery. His role at BeiGene allows him to collaborate with other experts in the field and contribute to groundbreaking research.
Collaborations
Some of Zhong Wu's notable coworkers include Lai Wang and Kang Li. Their combined expertise enhances the research environment and fosters innovation within the company.
Conclusion
Zhong Wu's contributions to immunotherapy represent a significant advancement in the fight against hepatocellular carcinoma. His innovative methods and collaboration with esteemed colleagues position him as a key figure in the ongoing development of effective cancer treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile